M-Trust™ is a secure cyber-physical trust platform that enables the creation of digital twins for enhanced product quality ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

DARMSTADT, Germany, Jan. 6, 2025 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company, ...

Most everyone has used Zoom since the pandemic, but have you mastered virtual backgrounds and filters? I interviewed Zoom ...

babul background This article will introduce you to the world's top 50 medical and health companies FDA approves first lupus nephritis treatment Merck's Keytruda was approved for a new indication and ...

Unlike in the 2014 Dungeons and Dragons rules, DnD 2024 backgrounds are now the source of a character’s ability score increases. Each One DnD background also offers a starting feat, a range of ...

We won't sugarcoat it, though; virtual reality can be an expensive hobby even within the gaming space, and individual headsets can cost as much as home consoles and even higher-end PC setups.

Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion. Under the terms of the deal, the company will gain the exclusive global ...

Merck (NYSE:MRK) and Chinese biopharmaceutical company Hansoh Pharma (OTCPK:HNSPF) announced a global licensing deal on Wednesday to develop HS-10535, an oral GLP-1 receptor agonist targeted at ...

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...

Dec 18 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's (3692.HK), opens new tab experimental oral drug to treat ...